Inspection Record

OmniaBio Inc. — Health Canada Inspection Findings

Health CanadaInspected 2026-09-21 6 findingsAseptic processing and sterility assuranceLaboratory and QC controlsDeviation, CAPA, and investigationTraining and personnel

View the regulator's official source The source document is always the basis for judgement.

Findings

1Aseptic processing and sterility assurance

The operators'aseptic practices were inadequate to maintain sterility.

2Laboratory and QC controls

The creation, maintenance, processing, and/or review of laboratory data was inadequate.

3Deviation, CAPA, and investigation

When the particulate and microbiological limits were exceeded, the company's operating procedures did not prescribe an investigation and implementation of corrective actions.

4Aseptic processing and sterility assurance

Evaluation of production processes, equipment, and/or materials was inadequate. The operators'aseptic practices were inadequate to maintain sterility.

5Aseptic processing and sterility assurance

The samples taken for sterility testing were not representative of the whole batch.

6Training and personnel

The training of personnel before new or revised standard operating procedures were implemented was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2026-09-21. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

OmniaBio Inc. findings history — including this company's other documentsAll Health Canada findings Health Canada documents, 2026 Go to Findings search
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.